GGrantIndex
Sort

64,565 grants matching drug discovery

Genetic Regulation of Arterial Wall by Canonical Wnt Signaling

$533,008
Arya Mani · Yale University · R01 · FY2015 · HL

Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs

$532,985
Macrae F Linton · Vanderbilt University Medical Center · R01 · FY2019 · HL

Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs

$532,985
Macrae F Linton · Vanderbilt University Medical Center · R01 · FY2017 · HL

Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs

$532,985
Macrae F Linton · Vanderbilt University Medical Center · R01 · FY2018 · HL

Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning

$532,962
Fang Zheng · University Of Kentucky · UG3 · FY2024 · NS

Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning

$532,962
Fang Zheng · University Of Kentucky · UG3 · FY2023 · NS

UCSD Cancer Center Training Program in Drug Development

$532,941
Stephen B Howell · University Of California, San Diego · T32 · FY2017 · CA

Epigenetic markers of severity in nonalcoholic fatty liver disease

$532,877
Johanna K Distefano · National Jewish Health · R01 · FY2017 · DK

Synthesis and Optimization of the Aleutianamine Class of Alkaloids

$532,866
Mark T Hamann · Medical University Of South Carolina · R01 · FY2023 · GM

Regulation of Sex Differences in Liver Metabolism

$532,861
David J Waxman · Boston University (Charles River Campus) · R01 · FY2016 · DK

Mechanism by which ketogenic diet uncouples tumor growth and overall survival

$532,591
Tobias Janowitz · Cold Spring Harbor Laboratory · R37 · FY2025 · CA

Mechanisms of Beta Cell Failure

$532,562
Domenico Accili · Columbia University Health Sciences · R01 · FY2021 · DK

Targeting Leukemic Stem Cells

$532,557
Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA

Systems Genetics of Vascular Smooth Muscle Phenotypes

$532,490
Mete Civelek · University Of Virginia · R01 · FY2025 · HL

Discovery of small molecule promoters of cardiomyocyte proliferation to restore cardiac performance in disease

$532,479
Alexandre Romain Colas · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · HL

Targeting Ferritin in Glioblastoma

$532,477
Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA

Dissecting local (N) and long range (Z) circuit modules within the spinal cord

$532,435
Samuel L. Pfaff · Salk Institute For Biological Studies · R01 · FY2024 · NS

Dissecting local (N) and long range (Z) circuit modules within the spinal cord

$532,435
Samuel L. Pfaff · Salk Institute For Biological Studies · R01 · FY2025 · NS

Targeting Ferritin in Glioblastoma

$532,412
Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA

New Modalities for the Treatment of Pain and Drug Abuse

$532,410
Frank Porreca · University Of Arizona · P01 · FY2019 · DA

Patient Derived Cancer Model (PDCM) Finder

$532,409
Helen Elizabeth Parkinson · European Molecular Biology Laboratory · U24 · FY2021 · CA

Self-propelled colloids in soft container: from motile droplets to active emulsions

$532,396
Petia M Vlahovska · Northwestern University · · FY2025 · MPS

Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis

$532,391
Maria Christina White · University Of Illinois At Urbana-Champaign · R35 · FY2018 · GM

Targeting Ferritin in Glioblastoma

$532,352
Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA

Reposition and Optimization of Deferiprone for Breast Cancer Therapy

$532,229
Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2023 · CA